WILLIAM DEMANT/ADR (OTCMKTS:WILYY) Downgraded by Zacks Investment Research

WILLIAM DEMANT/ADR (OTCMKTS:WILYY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, September 14th.

According to Zacks, “William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Company focuses on three business areas: Hearing Devices, Diagnostic Instruments and Personal Communication. William Demant Holding A/S is headquartered in Smorum, Denmark. “

Shares of WILYY stock traded down $1.48 during trading hours on Friday, hitting $17.91. 707 shares of the company were exchanged, compared to its average volume of 286. WILLIAM DEMANT/ADR has a 52-week low of $13.47 and a 52-week high of $23.90. The firm has a market cap of $10.62 billion, a P/E ratio of 34.44, a PEG ratio of 2.79 and a beta of 0.50.

WILLIAM DEMANT/ADR Company Profile

William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.

Further Reading: Do Tariffs Work?

Get a free copy of the Zacks research report on WILLIAM DEMANT/ADR (WILYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for WILLIAM DEMANT/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WILLIAM DEMANT/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply